Canopy Growth Corporation is a Canada-based company operating in the healthcare and consumer sectors, within the legal cannabis industry. The company cultivates, processes and commercializes cannabis-derived products for medical, recreational and wellness markets.

Its main areas of activity include:

• Cultivation and processing of cannabis products.
• Production of medical and recreational cannabis derivatives.
• Development of CBD-based wellness products.
• Commercialization of cannabis beverages, edibles and extracts.

Its portfolio includes brands such as Tweed, Tokyo Smoke, Spectrum Therapeutics and Martha Stewart CBD, covering a wide range of formats including dried flower, oils, edibles, beverages and topical products.

The company operates primarily in Canada, with structured participation in the United States and presence in Europe, Latin America and other international markets. Its infrastructure includes cultivation facilities, processing plants, laboratories, R&D centers and distribution networks aligned with regulatory requirements.

Industry dynamics affecting Canopy Growth include cannabis legislation, regulatory changes, consumer demand, pricing pressures, competition among producers, retail expansion and evolving international market access.

Shares of Canopy Growth Corporation trade on the Nasdaq under the ticker CGC.

History and Development

Canopy Growth was founded in 2013 under the name Tweed Marijuana Inc., becoming one of the first companies licensed to cultivate medical cannabis in Canada.

In its early years, the company expanded production capacity, developed distribution channels and became one of the first publicly traded cannabis producers, supporting industry growth and consolidation.

In 2016, the merger with Bedrocan Canada formed Canopy Growth Corporation, strengthening its position through increased scale and expanded capabilities.

The legalization of recreational cannabis in Canada in 2018 accelerated demand and led to significant investments in production, branding and retail partnerships. During this period, the company also received a major strategic investment from Constellation Brands, supporting expansion into new product categories.

In recent years, Canopy Growth has operated in a more challenging environment marked by oversupply, pricing pressure and regulatory complexity. The company has focused on restructuring operations, optimizing production and expanding its presence in higher-margin segments such as CBD and wellness products.

Additional Information

Canopy Growth Corporation (United States) is listed on the Nasdaq and has a market capitalization of $279.55 million, with shareholders equity totaling $490.69 million.

The company employs approximately 3.259 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Canopy Growth Corporation reported $212.00 million in revenue, generating net income of $-169.06 million.

Key financial metrics include a P/E ratio of -1.65, a price-to-book (P/B) ratio of 0.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CGC.